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Fifteen strains of an anaerobic, catalase-negative, gram-positive diphtheroid-shaped bacterium recovered
from human sources were characterized by phenotypic and molecular chemical and molecular genetic methods.
The unidentified bacterium showed some resemblance to Actinomyces species and related taxa, but biochemical
testing, polyacrylamide gel electrophoresis analysis of whole-cell proteins, and amplified 16S ribosomal DNA
restriction analysis indicated the strains were distinct from all currently named Actinomyces species and
related taxa. Comparative 16S rRNA gene sequencing studies showed that the bacterium represents a hitherto-
unknown phylogenetic line that is related to but distinct from Actinomyces, Actinobaculum, Arcanobacterium,
and Mobiluncus. We propose, on the basis of phenotypic and phylogenetic evidence, that the unknown bacte-
rium from human clinical specimens should be classified as a new genus and species, Varibaculum cambriensis
gen. nov., sp. nov. The type strain of Varibaculum cambriensis sp. nov. is CCUG 44998T  CIP 107344T.
The gram-positive, non-acid-fast, asporogenous, rod-shaped
organisms of the genus Actinomyces and related taxa (e.g.,
Actinobaculum, Arcanobacterium, and Mobiluncus) comprise a
phylogenetically heterogeneous group of organisms within the
high GC content Actinobacteria (18, 19). In recent years,
Actinomyces and related organisms have attracted the atten-
tion of clinical microbiologists, mainly because of a growing
awareness of their presence in clinical specimens and because
of their possible association with disease (7, 9). Many Actino-
myces species and related organisms belong to the facultative
anaerobic indigenous microflora of human and animal mucous
membranes, and some species are known to cause classical
actinomycosis and may also be found in polymicrobial infec-
tions, whereas others are significant in periodontal disease (18,
19). Knowledge of the interrelationships among Actinomyces
and related organisms has improved greatly in the past decade,
and the use of improved phenotypic and molecular diagnostic
methods of analysis has not only resulted in more reliable
species identification but has also facilitated the recognition of
many new taxa. Recently described Actinomyces and related
organisms from clinical specimens include Actinomyces funkei
(12), Actinomyces europaeus (4), Actinomyces graevenitzii (15),
Actinomyces neuii subspp. anitratus and neuii (6), Actinomyces
radingae (22), Actinomyces radicidentis (2), Actinomyces turi-
censis (22), Actinomyces urogenitalis (14), Actinobaculum
schaalii (11), and Arcanobacterium bernardiae (5) where they
occur as contaminants and/or represent possible opportunistic
human pathogens. Despite the plethora of new species defined
from human sources in recent years, it is clear that information
on the habitats, clinical prevalence, and pathogenic potential
of many Actinomyces and related organisms is inadequate, and
there are indications (8, 9) that much new diversity still re-
mains to be discovered. During the course of an investigation
into taxonomically problematic Actinobacteria from clinical
specimens we characterized a novel organism that represents a
hitherto-unknown genus related to, but distinct from, Actino-
myces and its near relatives.
MATERIALS AND METHODS
Cultures and phenotypic characterization. Fifteen strains were analyzed, ten
of which originated in polymicrobial infections and were isolated in the United
Kingdom. These were presumptively identified as Actinomyces spp. and were
referred to the Public Health Laboratory Service Anaerobe Reference Unit,
Cardiff, United Kingdom, for confirmation of identity. Strain R5231 (CCUG
[Culture Collection of the University of Göteborg] 44992) was isolated from a
cerebral abscess of a 6-year-old girl in London 1993. The patient had a long
history of ear and mastoid problems prior to emergency admission for surgical
drainage of the abscess, from which “mixed anaerobes” were isolated. Initially,
the patient responded well to therapy with benzylpenicillin, cefotaxime, and
metronidazole, but she was readmitted with seizures some 3 weeks later. Pus
drained from the reformed cerebral abscess yielded Peptostreptococcus anaero-
bius, Peptoniphilus asaccharolyticus, Porphyromonas endodontalis, Prevotella cor-
poris, Prevotella oralis, Propionibacterium sp., Bifidobacterium sp., and strain
R5231, originally reported as Actinomyces meyeri (1). Treatment with metroni-
dazole and clindamycin resulted in a good recovery. Strain R12359 (CCUG
44998T) was isolated from a postauricular abscess of a 27-year-old male (Lon-
don, 1998), strain R13662 (CCUG 45111) was isolated from a large ischiorectal
abscess of a 24-year-old female (Merthyr Tydfil, 1999), and strain R13224 was
isolated from a submandibular abscess of a 20-year-old male (Farnborough,
1999). Three strains were isolated from breast abscesses: R3521 (CCUG 45113)
from a female of unknown age (Nottingham, 1989); R5619, which was isolated
with mixed obligate anaerobes from a 29-year-old male (London, 1993); and
R16017, which was isolated with an unidentified diphtheroid from a 49-year-old
female (Merthyr Tydfil, Wales, 2001). Strains R11462 (CCUG 45112) and
R16101 were isolated from intrauterine contraceptive devices (IUCDs) from a
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33-year-old (Farnborough, 1997) and a 42-year-old (Oxford, 2001), respectively,
and strain R4898 was from a high vaginal swab of a female of unknown age with
an IUCD in situ (London, 1992). The remaining five strains came from Scabdi-
navia: four from Sweden and one strain from Norway. The Scandinavian strains
were submitted to the CCUG collection for identification. The sources of these
were as follows: strains CCUG 20976 and CCUG 20977 were from an abscess of
a 28-year-old female in Skövde in 1987, strain CCUG 37510 was from a case of
hidradenitis in a 37-year-old male (Stockholm, 1997), strain CCUG 46939 was
from a fistula of a 57-year-old female (Kalmar, 2002), and strain CCUG 34258
was from a cheek abscess (Tromsö, 1995). The unidentified isolates were cul-
tured anaerobically on Columbia agar (Difco, Detroit, Mich.) supplemented with
5% horse blood at 37°C for 48 h. The strains were characterized by using
conventional tests (16) and the commercially available API Rapid ID 32Strep,
API Zym, and API Coryne systems according to the manufacturer’s instructions
(API bioMérieux, Marcy l’Étoile, France). Volatile and nonvolatile end products
of glucose metabolism were examined by gas-liquid chromatography (10).
DNA base composition determination. For the determination of GC con-
tent, DNA was isolated after disruption of cells by using a French pressure cell
and purified by hydoxyapatite. The mol% GC content was determined by
high-pressure liquid chromatography after digestion of DNA with P1 nuclease
and alkaline phosphatase as described by Mesbah et al. (13).
Amplified 16S rDNA restriction analysis. Amplified 16S ribosomal DNA
(rDNA) restriction analysis (ARDRA) were performed by using HaeIII and
HpaII as described previously (8, 9).
16S rRNA gene sequencing and phylogenetic analyses. The 16S rRNA genes
of five isolates were amplified by PCR and directly sequenced by using a Taq
dye-deoxy terminator cycle sequencing kit (Applied Biosystems, Foster City,
Calif.) and an automatic DNA sequencer (model 373A; Applied Biosystems).
The closest known relatives of the new isolates were determined by performing
GenBank/EMBL database searches. These sequences and those of other known
related strains were retrieved from GenBank/EMBL and aligned with the newly
determined sequences by using the program CLUSTALW (21). The resulting
multiple sequence alignment was corrected manually and a distance matrix was
calculated by using DNADIST (using the Kimura-2 correction parameter) (3). A
phylogenetic tree was constructed according to the neighbor-joining method with
the program NEIGHBOR (3). The stability of the groupings was estimated by
bootstrap analysis (1000 replications) by using the programs DNABOOT, DNA-
DIST, NEIGHBOR, and CONSENSE (3).
Protein profiling. Polyacrylamide gel electrophoresis (PAGE) analysis of
whole-cell proteins was performed as described by Pot et al. (17). For densito-
metric analysis, normalization and interpretation of protein patterns the GCW
3.0 software package (Applied Maths) was used. The similarity between all pairs
of traces was expressed by the Pearson product moment correlation coefficient
converted for convenience to a percentage similarity.
GenBank accession number. The 16S rRNA gene sequence of strain CCUG
44998T has been deposited in GenBank under accession number AJ491326.
RESULTS AND DISCUSSION
The isolates consisted of gram-positive, short, straight or
curved diphtheroid-shaped rods, which were non-acid fast and
non-spore-forming. After anaerobic incubation for 48 to 72 h
on Columbia agar or Fastidious Anaerobe Agar (LabM, Bury,
United Kingdom) with horse blood (5%), the colonies were
pinpoint, convex, entire-edged, translucent white or gray, glis-
tening, and nonhemolytic. Strains grew well or poorly in air
plus 5% CO2 and poorly or not at all in air. The strains were
catalase negative and biochemically closely resembled each
other. Thirteen strains were subjected to conventional bio-
chemical testing, and all of these strains formed acid from
D-glucose, sucrose, and D-ribose. Some strains also formed acid
from fructose, mannitol, and xylose, but none produced acid
from amygdalin, L-arabinose, cellobiose, lactose, mannose, D-
raffinose, salicin, or trehalose. All of the strains were lecithi-
nase and lipase negative, and none formed indole. None of the
isolates hydolyzed esculin, gelatin, or starch, but all reduced
nitrate to nitrite. With the API Zym system, all of the strains
were -glucosidase and leucine arylamidase positive; reactions
for acid phosphatase, phosphoamidase, esterase C-4, and ester
lipase C8 were either weakly positive or negative. All other
tests in the API Zym system were negative. Using the API
Coryne system, the isolates produced acid from D-glucose,
maltose, and sucrose, and all were -glucosidase positive.
Some strains produced acid from D-ribose and D-xylose. None
of the strains formed acid from glycogen, lactose, or mannitol,
and activity for alkaline phosphatase, -galactosidase, -glu-
curonidase, N-acetyl--glucosaminidase, pyrolidonyl arylami-
dase, pyrazinamidase, and urease was not detected. The nu-
merical codes thus generated are listed in Table 1. In the
manufacturer’s database, these were identified as doubtful or
unacceptable profiles for Corynebacterium diphtheriae var. bel-
fanti or Corynebacterium diphtheriae var. mitis. However, the
novel bacterium is clearly distinguished from these species by
its negative catalase reaction, its ability to ferment sucrose, and
its poor growth under aerobic conditions. Using the API Rapid
ID 32Strep system, 7 of 10 strains formed acid from sucrose
and 9 of 10 strains hydrolyzed hippurate. Some strains pro-
duced acid from maltose (4 of 10), D-ribose (3 of 10), and
trehalose (2 of 10), and some showed activity for alanine phe-
nylalanine proline arylamidase (6 of 10) and -galactosidase
(weak reactions, 2 of 10). All other tests in the API Rapid ID
32Strep system were negative. The numerical codes thus gen-
erated are listed in Table 1. In the manufacturer’s database, all
of the seven codes obtained were interpreted as good to ex-
cellent identifications of Streptococcus acidominimus. How-
ever, each strain of the novel bacterium produced one or more
reactions that contradicted this identification, namely, negative
alanine phenylalanine proline arylamidase, negative trehalose,
positive ribose, and/or positive -galactosidase reactions. Fur-
thermore, cellular morphology clearly distinguishes the novel
bacterium from Streptococcus spp. Commercial biochemical
test systems such as the API Rapid ID 32Strep and Coryne kits
have been used widely in the phenotypic differentiation of
recently described novel bacteria, including Actinomyces spp.
and related organisms (2, 4, 11, 12, 14, 15). These systems are
very useful, standardized methods for the identification of
many organisms from clinical sources. However, reliance upon
the manufacturer’s databases commonly leads to unacceptable
or erroneous identifications due to the lack of regular updating
of these databases. Clinical microbiologists should be aware of
these shortcomings and should interpret results obtained in
these systems with reference to the most recently published
data and in conjunction with other findings such as cellular and
colony morphology.
The cellular morphology and biochemical reactions of the
novel isolates somewhat resembled the genus Actinomyces, but
TABLE 1. Numerical codes for Varibaculum cambriensis obtained
with the API Rapid ID 32Strep and Coryne test systems
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the isolates did not appear to correspond to any recognized
species of this genus or related taxa (e.g., Arcanobacterium,
Actinobaculum, and Mobiluncus). To investigate the genetic
relatedness of the isolates, ARDRA was performed. Two char-
acteristic 16S rDNA restriction profiles, designated 035/023
and 034/014, were obtained that were distinct from those of
recognized Actinomyces, Arcanobacterium, Actinobaculum, and
Mobiluncus species. To ascertain the phylogenetic relation-
ships of the clinical isolates, their 16S rRNA genes were se-
quenced and subjected to a comparative analysis. The almost-
complete gene sequences (1,400 nucleotides) of the strains
were determined, and pairwise analysis showed these to be
almost identical (99.1 to 100% sequence similarity). Sequence
database searches showed that the unknown bacterium was
most closely related to the high GC gram-positive Actinobac-
teria, with highest sequence similarities shared with Actinomy-
ces, Arcanobacterium, Actinobaculum, and Mobiluncus species.
Treeing analysis confirmed the association of the unknown
clinical bacterium (as exemplified by strain CCUG 44998T)
with the aforementioned taxa, with the unknown organism
forming a relatively long and distinct line of descent among the
Actinomyces and related taxa (Fig. 1). To assess the phenotypic
homogeneity of the clinical isolates, PAGE of whole-cell pro-
teins was performed, and their profiles were compared to each
other and to reference Actinomyces, Arcanobacterium, Acti-
nobaculum, and Mobiluncus species. The 15 isolates closely
resembled each other, forming a distinct and robust group,
which was distinct from all reference species examined (data
not shown). A dendrogram from a subset of these analyses,
showing the high affinity between the clinical isolates and their
separateness from Mobiluncus species, is shown in Fig. 2.
It has become apparent from 16S rRNA gene sequencing
that the genus Actinomyces is phylogenetically very heteroge-
neous and consists of several rRNA lines, some of which are
equivalent in rank to other related genera such as Arcanobac-
terium and Mobiluncus (2, 14). It is evident from the present
16S rRNA analysis that the Actinomyces-like organisms from
human clinical specimens represent a hitherto-unknown bac-
terium among the phylogenetic radiation of Actinomyces and
related genera. Phylogenetically, the novel bacterium forms a
long and deep line, which forms a loose association with Acti-
nomyces neuii and species of the genus Mobiluncus. Bootstrap
resampling, however, showed that the branching of the novel
organism with Actinomyces neuii and the genus Mobiluncus was
not statistically significant. Furthermore, sequence divergence
values of ca. 10 to 12% with the aforementioned taxa unequiv-
ocally demonstrate the novel bacterium from human sources
represents a distinct taxon, one worthy of a separate generic
status. Phenotypically, the unknown bacterium can be readily
identified and distinguished from all currently recognized Ac-
FIG. 1. Unrooted tree showing the phylogenetic relationships of Varibaculum cambriensis and its nearest relatives. The tree, constructed by
using the neighbor-joining method, was based on a comparison of ca. 1,327 nucleotides. Bootstrap values, expressed as a percentage of 1,000
replications, are given at the branching points.
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tinomyces species and related taxa by using commercially avail-
able biochemical kits. Although the novel bacterium shows a
phylogenetic association with Actinomyces neuii (6) and Mobi-
luncus species (20), it is phenotypically quite distinct from
these taxa. Tests that are useful in distinguishing the novel
bacterium from Actinomyces neuii include its negative reac-
tions for catalase, pyrazinamidase, -galactosidase, and -ga-
lactosidase, whereas Actinomyces neuii gives positive reactions
for these enzymes. Phenotypically, the novel bacterium differs
from Mobiluncus species in being nonmotile. The unidentified
bacterium can be differentiated by using the API Rapid ID
32Strep system from Mobiluncus mulieris by its ability to hy-
drolyze hippurate and can be distinguished from Mobiluncus
curtisii by its failure to produce -galactosidase, -galactosi-
dase, or arginine dihydrolase. Protein profiling further demon-
strated the phenotypic coherence of the novel bacterium and
its separateness from the two currently recognized Mobiluncus
species. In addition, the novel bacterium can be distinguished
from Actinomyces species by using a combination of biochem-
ical tests. Its negative catalase reaction distinguishes the novel
bacterium from the many catalase-positive species encoun-
tered in clinical specimens. Tests that are helpful in the routine
laboratory to distinguish the unidentified bacterium from cata-
lase-negative Actinomyces species with which it may be con-
fused are shown in Table 2. Although clear differentiation from
Actinomyces turicensis by using the tests indicated in Table 2
may sometimes be problematic, these species may be further
distinguished by the ability of the unidentified bacterium to
reduce nitrate to nitrite. Therefore, based on both phenotypic
and molecular genetic evidence, we consider the 15 clinical
isolates merit classification as a new genus and species, Vari-
baculum cambriensis, within the Actinomyces suprageneric
grouping. To date, Varibaculum cambriensis has been isolated
in the United Kingdom and Scandinavia from various human
sites, including abscesses of the head and breast and IUCDs.
The polymicrobial nature of these infections and a paucity of
clinical information preclude ascertainment of its clinical sig-
nificance at present. Its occurrence in facial abscesses and in an
otogenic cerebral abscess, together with mixed anaerobes
known to be of oral origin (1), suggests that the novel bacte-
FIG. 2. Similarity dendrogram based on whole-cell protein patterns of Varibaculum cambriensis sp. nov. and Mobiluncus species. The levels of
correlation are expressed as percentages of similarity for convenience.
TABLE 2. Tests that are useful in distinguishing Varibaculum cambriensis from catalase-negative Actinomyces species
with which it may be confused
Test type
Test resulta
V. combriensis A. europaeus A. funkei A. georgiae A. meyeri A. odontolyticus A. radingae A. turicensis
Acid from:
Lactose      V V 
Melibiose  V      
Pullulan  V    V  
Raffinose        
Ribose V V V    V V
Sucrose V     V V 
Trehalose V V     V 
Methyl-BD       V 
Hydrolysis of hippurate        
Production of:
-Gal        
-Gal V  V   V  
PAL        
APPA V       
a Tests were performed by using API Rapid ID 32Strep system. Results : , positive; , negative; V, variable.
b Methyl-BD, methyl--D-glucopyranoside; -Gal, -galactosidase; -Gal, -galactosidase; PAL, alkaline phosphatase; APPA, alanine phenylalanine proline
arylamidase.
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rium may occupy a similar habitat. We believe the formal
description of this new species will facilitate its identification in
the clinical laboratory, thereby permitting a future evaluation
of its distribution and clinical significance.
Description of Varibaculum gen. nov. Varibaculum (va.ri.
bacu.lum. L. adj. varus, bent; L. neut. n. baculum, small rod;
N.L. neut. n. varibaculum, small bent rod) cells consist of short,
straight or curved diphtheroid rods which stain gram positive
and are non-acid fast and nonmotile, nonhemolytic, anaerobic,
and catalase negative. Acid is produced from glucose and some
other sugars. Lactic and succinic acids are the major end prod-
ucts of glucose metabolism. Hippurate is hydrolyzed, but es-
culin, gelatin, and starch are not hydrolyzed. Acetoin is not
produced. It is -glucosidase and leucine arylamidase positive
and arginine dihydrolase, pyrazinamidase, urease, and indole
negative. Nitrate is reduced to nitrite by the majority of iso-
lates. The GC content of DNA is 51.7 mol%. The type
species is Varibaculum cambriensis.
Description of Varibaculum cambriensis sp. nov. Varibaculum
cambriensis (cam.bri.ensis. L. adj. cambriensis, pertaining to
cambria, the Latin name of Wales) cells consists of short,
straight or curved diphtheroid rods which stain gram-positive
and are non-acid-fast and nonmotile. Colonies after 48 h an-
aerobic incubation on Fastidious Anaerobic Agar with 5%
horse blood are pinpoint, convex, entire edged, glistening,
translucent white or gray. It is nonhemolytic, anaerobic, and
catalase-negative. The end products of glucose metabolism are
lactic and succinic acids, together with small amounts of acetic
acid. Using conventional biochemical testing, acid is formed
from D-glucose, sucrose, and D-ribose; acid may or may not be
formed from fructose, mannitol, and xylose. Acid is not pro-
duced from amygdalin, L-arabinose, cellobiose, lactose, man-
nose, D-raffinose, salicin, or trehalose. It is lecithinase and
lipase negative and indole negative. Esculin, gelatin, and starch
are not hydrolyzed. Using API test systems, acid is produced
from D-glucose, and most strains ferment sucrose. Some strains
produce acid from maltose, D-ribose, trehalose and D-xylose.
Acid is not produced from D-arabitol, L-arabinose, cyclodex-
trin, glycogen, mannitol, melibiose, melezitose, methyl--D-
glucopyranoside, lactose, pullulan, D-raffinose, sorbitol, or ta-
gatose. Hippurate is hydrolyzed by most strains, but esculin
and gelatin are not hydrolyzed. Activity for -glucosidase and
leucine arylamidase are detected, and some strains display
activity for alanine phenylalanine proline arylamidase and
-galactosidase (weak reaction). Activity for acid phosphatase,
esterase C-4, ester lipase C8, and phosphoamidase is either
weakly positive or negative. No activity is detected for arginine
dihydrolase, alkaline phosphatase, chymotrypsin, -fucosidase,
-galactosidase, -glucosidase, -glucuronidase, glycyl trypto-
phane arylamidase, lipase C14, -mannosidase, -mannosi-
dase, N-acetyl--glucosaminidase, pyrolidonyl arylamidase, py-
roglutamic acid arylamidase, pyrazinamidase, trypsin, valine
arylamidase, or urease. Most strains reduce nitrate to nitrite.
Acetoin is not produced. The GC content of DNA is 51.7
mol%. It is isolated from human sources, including breast
abscess, brain abscess, cheek abscess, submandibular abscess,
postauricular abscess, ischiorectal abscess, and intrauterine
contraceptive devices. The habitat is not known. The type
strain is CCUG 44998T  CIP 107344T.
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